Hemoglobin betafumaril (bovine) injection
Hemoglobin betafumaril (bovine) injection

Oxapex® is a sterile hemoglobin-based therapeutic which could bring about the increase in systemic plasma hemoglobin concentrations after infusion.  Serving to provide additional oxygen carrying support and improve tissue oxygenation, it could alleviate clinical signs and symptoms of animals suffering from anemia caused by hemorrhagic shock.

Oxapex® is manufactured from controlled bovine blood source originated from New Zealand which has been recognized as a country with negligible bovine spongiform encephalopathy (BSE) risk status by the World Organization for Animal Health (OIE).

Product Features

  • Hypoxia regulation
  • Rapid onset of action
  • Convenient to use
  • Readily available

Clinical Application

Anemia caused by hemorrhagic shock

How Supplied

The product is supplied in infusion bag. The bag is overwrapped with an aluminium pouch, and then packed into a cardboard box.
Each cardboard box contains 2 bags of product.
Pack size: 20 mL and 100 mL.

Oxapex®IDX (20 mL) is a veterinary prescription medicine available in the USA.
LEGAL STATUS—In order to be legally marketed, a new animal drug intended for a minor species must be Approved, Conditionally Approved, or Indexed by the Food and Drug Administration. THIS PRODUCT IS INDEXED—MIF #900-018.
For use in captive mustelids, captive rodents, raptors, and captive or pet birds of the orders Psittaciformes, Passeriformes, and Columbiformes.

Oxapex® (100 mL) is a veterinary prescription medicine registered in New Zealand for use in dogs. ACVM Registration No. A010809.




For further information, please contact:
New Alpha Innovation Limited
Email: newaiinfo@newalphainnovation.com





× We use page tagging techniques and cookies to improve the site, provide services to you, and customize your browsing experience. By continuing to browse the site you are agreeing to accept our use of cookies